Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Affimed N.V.
  6. News
  7. Summary
    AFMD   NL0010872420

AFFIMED N.V.

(AFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Press Release : Affimed Announces Publication of -2-

05/13/2021 | 04:01pm EDT
other factors, you should not place undue reliance on these 
forward-looking statements, and we assume no obligation to update these 
forward-looking statements, even if new information becomes available in 
the future. 
 
   # # # 
 
   Investor Relations Contact 
 
   Alexander Fudukidis 
 
   Director, Head of Investor Relations 
 
   https://www.globenewswire.com/Tracker?data=9cav7sbp26PnKlyroosoAQ0yDvjW_eT91xV0VaOcmYucahWmCDZTtJfq2fNJC0qDpnqfrtn9mQyUkk7FJKaPLT4oj-ZWVqtg7HsngZ6avkw= 
a.fudukidis@affimed.com 
 
   Tel.: +1 (917) 436-8102 
 
   Media Contact 
 
   Mary Beth Sandin 
 
   Vice President, Marketing and Communications 
 
   https://www.globenewswire.com/Tracker?data=Lyt4dixOHhSorqmvUpRg7eu7zM7qP8sAHddoGnA8RhHpGsi9PGcVbpkWUZTpGJE4cNd86-MCbyIr69FNkpM28fJlQVmPUPBdNU8WSk0e94o= 
m.sandin@affimed.com 
 
   Tel: +1 (484) 888-8195 
 
 
 
 

(END) Dow Jones Newswires

May 13, 2021 16:01 ET (20:01 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
AFFIMED N.V. -2.64% 6.65 Delayed Quote.14.26%
DJ INDUSTRIAL -0.42% 34935.47 Delayed Quote.14.63%
All news about AFFIMED N.V.
07/30AFFIMED N : Announces Publication of Comprehensive Preclinical Data Demonstratin..
AQ
07/30Affimed N.V. Announces Publication of Comprehensive Preclinical Data Demonstr..
CI
07/01AFFIMED N : Q1 Revenue Advances
MT
07/01AFFIMED N : Unaudited consolidated statements of comprehensive income / (loss) (..
PU
07/01AFFIMED N : Reports First Quarter 2021 Financial Results and Highlights Operatio..
PU
07/01Affimed Reports First Quarter 2021 Financial Results and Highlights Operation..
GL
06/22Affimed to Report First Quarter 2021 Financial Results & Corporate Update Jul..
GL
06/16AFFIMED N : Annual General Meeting Results (Form 6-K)
PU
06/16Affimed N.V. Appoints Denise Mueller to the Management Board
CI
06/16Affimed N.V. Appoints Uta Kemmerich-Keil as Director on Its Supervisory Board
CI
More news
Financials
Sales 2021 36,2 M 43,0 M 43,0 M
Net income 2021 -28,7 M -34,0 M -34,0 M
Net Debt 2021 - - -
P/E ratio 2021 -22,4x
Yield 2021 -
Capitalization 667 M 791 M 791 M
Capi. / Sales 2021 18,4x
Capi. / Sales 2022 11,3x
Nbr of Employees 153
Free-Float 97,2%
Chart AFFIMED N.V.
Duration : Period :
Affimed N.V. Technical Analysis Chart | AFMD | NL0010872420 | MarketScreener
Technical analysis trends AFFIMED N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 5,60 €
Average target price 12,66 €
Spread / Average Target 126%
EPS Revisions
Managers and Directors
Adolf Hoess Chief Executive Officer
Angus W. Smith Chief Financial Officer
Thomas O. Hecht Chairman-Supervisory Board
Andreas Harstrick Chief Medical Officer
Arndt Schottelius Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
AFFIMED N.V.14.26%791
GILEAD SCIENCES, INC.19.86%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.33.61%59 516
REGENERON PHARMACEUTICALS20.70%59 505
VERTEX PHARMACEUTICALS-14.71%52 296